Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-26 225793
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Anticipated shortage 2024-01-19 2024-02-06 216702
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-05-08 216705
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-RIZATRIPTAN RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2020-07-06 490
APO-RIZATRIPTAN RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2018-09-11 493
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-13 2017-07-31 12689
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-08-08 2017-08-23 18546
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-03 2018-01-29 24277
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-12 2018-09-12 25649
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2018-08-15 29036
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-15 2018-01-31 29348
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-09-04 44507
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-08-15 44510
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-12-12 2019-03-29 69318
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-04 2019-10-01 92984

Showing 2981 to 3000 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-CICLESONIDE 50MCG SPRAY, METERED DOSE Discontinued 2018-12-20 2018-12-21 70250
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-NITRAZEPAM 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-NITRAZEPAM 10MG TABLET Discontinued 2017-03-13 2018-12-07 1117

Showing 101 to 120 of 356